Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '2510.006.19

Profile

Edit
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
URL https://www.kezarlifesciences.com
Investor Relations URL https://ir.kezarlifesciences.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 14, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
URL https://www.kezarlifesciences.com
Investor Relations URL https://ir.kezarlifesciences.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 14, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows